NewGenIvf (NIVF) Revenue (2024 - 2025)
NewGenIvf (NIVF) posted quarterly Revenue of $1.4 million for Q4 2025, up 11.85% year-over-year from $1.3 million in Q4 2024, and up 11.1% quarter-over-quarter from $1.3 million in Q3 2025.
Powered by 
Analysis
NewGenIvf (NIVF) Revenue (2024 - 2025) Analysis & Trends
NewGenIvf (NIVF) has reported Revenue for 2 consecutive years, with $1.4 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Revenue rose 11.85% year-over-year to $1.4 million; the TTM figure through Dec 2025 stood at $5.5 million (changed N/A YoY), while the FY2025 annual figure was $4.7 million, down 13.01% from the prior year.
- Revenue advanced to $1.4 million in Q4 2025 per NIVF's latest filing, from $1.3 million in the prior quarter.
- Across five years, Revenue topped out at $1.5 million in Q3 2024 and bottomed at $1.3 million in Q4 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | HCA Healthcare | 90.36 Bn | 89.35 Bn | 15.19 Bn | 20.23 Bn |
| 2 | Tenet Healthcare | 22.02 Bn | 19.85 Bn | 4.45 Bn | 5.63 Bn |
| 3 | Encompass Health | 12.13 Bn | 11.99 Bn | 1.34 Bn | 1.60 Bn |
| 4 | Davita | 11.78 Bn | 11.09 Bn | 1.16 Bn | 3.55 Bn |
| 5 | Universal Health Services | 10.09 Bn | 9.95 Bn | 3.29 Bn | 4.64 Bn |
| 6 | Ensign | 9.97 Bn | 9.65 Bn | 306.24 Mn | 1.44 Bn |
| 7 | Chemed | 6.93 Bn | 6.89 Bn | 221.47 Mn | 673.25 Mn |
| 8 | Pacs | 6.81 Bn | 6.64 Bn | 338.46 Mn | 1.43 Bn |
| 9 | Concentra Group Holdings Parent | 4.32 Bn | 4.16 Bn | 192.10 Mn | 606.03 Mn |
| 10 | NewGenIvf | 5,955.48 | -2.32 Mn | 524,025.00 | 1.42 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 1.42 Mn |
| Sep 30, 2025 | 1.28 Mn |
| Dec 31, 2024 | 1.27 Mn |
| Sep 30, 2024 | 1.47 Mn |